Stryker Q1 FY26 net earnings rise 13.9% to $745 million; net sales climb 2.6% to $6.02 billion

Stryker Corporation

Stryker Corporation

SYK

0.00
  • Stryker posted net earnings of USD 745 million, up 13.9%, while net earnings per diluted share rose 14.2% to USD 1.93.
  • Net sales increased 2.6% to USD 6.02 billion, led by 5% growth in MedSurg and Neurotechnology to USD 3.21 billion.
  • Operating income climbed to USD 936 million, lifting operating margin 1.2 percentage points to 15.5%.
  • Gross margin narrowed 0.5 percentage points to 63.3% due to higher manufacturing and supply chain costs tied to idle production time from a cybersecurity incident.
  • During quarter, Stryker announced a reorganization that created Ortho Tech, combining orthopaedic instruments with Mako and enabling technologies under Orthopaedics.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stryker Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000310764-26-000031), on May 11, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.